Clinical Trials and Preclinical Infrastructure Asset Map - Life Sciences
Clinical Trials and Preclinical Infrastructure Asset Map - Life Sciences
Clinical Trials and Preclinical Infrastructure Asset Map - Life Sciences
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
CLINICAL TRIALS AND PRECLINICAL INFRASTRUCTURE ASSET MAP<br />
35<br />
Name of Facility (URL) Description Contact<br />
Pharmaceutical Outcomes <strong>and</strong> Policy<br />
Innovations, B.C. Children’s Hospital<br />
(POPi) (www.popi.ubc.ca)<br />
University of Victoria Pharmaceutical<br />
Outcomes <strong>and</strong> Policy Innovation (no<br />
URL)<br />
Pediatric research unit that fosters<br />
pharmaceutical policy innovation through<br />
proactive policy research, training <strong>and</strong><br />
knowledge translation concerning the effectiveness,<br />
safety, <strong>and</strong> cost management<br />
of prescription drugs. Its three general<br />
components are: Drug Safety, Drug Effectiveness,<br />
Drug Policy.<br />
Research unit that studies drug effectiveness,<br />
safety <strong>and</strong> costs to provide decision<br />
makers with cost effective drug coverage<br />
strategies that produce the best health<br />
outcomes.<br />
Carleton, Bruce, Director.<br />
T: 604-875-3609.<br />
bcarleton@popi.ubc.ca<br />
Warburton, Rebecca. Assistant Professor.<br />
T: 250-721-8066.<br />
rnwarbur@uvic.ca<br />
Epidemiology <strong>and</strong> Surveillance Facilities<br />
B.C. is home to numerous epidemiologists who work in public/ population/ community/ environmental<br />
health. This <strong>Asset</strong> <strong>Map</strong> lists some of the researchers that combine epidemiology with new treatment<br />
options <strong>and</strong>/or interventions (lifestyle modification) in Appendix 6. In addition, a number of the Province’s<br />
health research centres have epidemiology or surveillance divisions. Thirteen of these are listed in<br />
Table 10; details can be found in Appendix 9 unless otherwise stated.<br />
TABLE 10. Epidemiology <strong>and</strong> Surveillance Facilities<br />
Facility (URL) Description Contact<br />
Arthritis Research Centre of Canada,<br />
VGH<br />
Described above in Table 9.<br />
B.C. Centre for Disease Control,<br />
Epidemiology Division <strong>and</strong> Immunization<br />
Programs<br />
(http://www.bccdc.ca/util/about/div/<br />
epidemioligy/default.htm)<br />
Centre for Aboriginal Health Research<br />
(CAHR) (www.cahr.uvic.ca)<br />
• Epidemiology Division - Provincial reporting<br />
centre for cases of communicable<br />
disease - monitors <strong>and</strong> evaluates cases<br />
<strong>and</strong> outbreaks, develops prevention <strong>and</strong><br />
control policies <strong>and</strong> programs, <strong>and</strong> supports<br />
the implementation of immunization<br />
programs<br />
• Adverse events surveillance system for<br />
monitoring the public administration<br />
of vaccines (part of its Immunization<br />
Programs).<br />
Research projects in diverse areas of<br />
Aboriginal health including: chronic<br />
disease, disability, First Nations health,<br />
knowledge translation, epidemiology,<br />
global indigenous health, participatory<br />
<strong>and</strong> collaborative community-based<br />
research, <strong>and</strong> health disparities.<br />
Epidemiology Division.<br />
T: 604-707-2510.<br />
Surveillance: Naus, Monika.<br />
T: 604-707-2400.<br />
Monika.naus@bccdc.ca<br />
Lalonde, Chris. Associate Director.<br />
T: 250-721-7535.<br />
lalonde@uvic.ca